MX2015015176A - Composiciones antimicrobianas y metodos para su produccion. - Google Patents

Composiciones antimicrobianas y metodos para su produccion.

Info

Publication number
MX2015015176A
MX2015015176A MX2015015176A MX2015015176A MX2015015176A MX 2015015176 A MX2015015176 A MX 2015015176A MX 2015015176 A MX2015015176 A MX 2015015176A MX 2015015176 A MX2015015176 A MX 2015015176A MX 2015015176 A MX2015015176 A MX 2015015176A
Authority
MX
Mexico
Prior art keywords
infections
compositions
methods
composition
treating
Prior art date
Application number
MX2015015176A
Other languages
English (en)
Other versions
MX366894B (es
Inventor
Vincent O'flaherty
Paul Mccay
Original Assignee
Nat Univ Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Univ Ireland filed Critical Nat Univ Ireland
Publication of MX2015015176A publication Critical patent/MX2015015176A/es
Publication of MX366894B publication Critical patent/MX366894B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/082—Inorganic materials
    • A61L31/088—Other specific inorganic materials not covered by A61L31/084 or A61L31/086
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/11—Peroxy compounds, peroxides, e.g. hydrogen peroxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La presente invención se refiere a un método para la preparación de composiciones para prevenir o tratar infecciones microbianas, a composiciones adecuadas para su uso en tales tratamientos y a métodos para el tratamiento o la prevención de infecciones. Una de tale composiciones encuentra uso particular en el tratamiento de la mastitis en rumiantes. La composición se administra en la ubre de un animal como un tratamiento altamente efectivo para la mastitis, o como terapia profiláctica, por medio de una infusión intramamaria. La leche producida por el animal, durante el tratamiento usando la composición y el método de la invención, está libre de residuos, tales como antibióticos, agentes antimicrobianos o proteínas antimicrobianas, que podrían afectar a su idoneidad para beber o a la producción de productos lácteos, tales como queso o yogur. Las composiciones y los métodos también son útiles para tratar y prevenir las infecciones pulmonares; y las infecciones en quemaduras y heridas; y otras infecciones causadas por películas biológicas. Las composiciones también se pueden utilizar con dispositivos médicos para prevenir la infección.
MX2015015176A 2013-05-01 2014-04-29 Composiciones antimicrobianas y métodos para su producción. MX366894B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13166137.3A EP2799068A1 (en) 2013-05-01 2013-05-01 Antimicrobial compositions and methods for their production
PCT/EP2014/058766 WO2014177590A1 (en) 2013-05-01 2014-04-29 Antimicrobial compositions and methods for their production

Publications (2)

Publication Number Publication Date
MX2015015176A true MX2015015176A (es) 2016-06-02
MX366894B MX366894B (es) 2019-07-29

Family

ID=48190375

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015015176A MX366894B (es) 2013-05-01 2014-04-29 Composiciones antimicrobianas y métodos para su producción.

Country Status (10)

Country Link
US (2) US20160074436A1 (es)
EP (3) EP2799068A1 (es)
JP (2) JP6783139B2 (es)
CN (1) CN105263489B (es)
AU (3) AU2014261429B2 (es)
BR (1) BR112015027636A2 (es)
CA (1) CA2910243A1 (es)
MX (1) MX366894B (es)
PL (1) PL2991642T3 (es)
WO (1) WO2014177590A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2856196C (en) 2011-12-06 2020-09-01 Masco Corporation Of Indiana Ozone distribution in a faucet
CN108463437B (zh) 2015-12-21 2022-07-08 德尔塔阀门公司 包括消毒装置的流体输送系统
US11026966B2 (en) 2018-05-02 2021-06-08 Purina Animal Nutrition Llc Animal feed products containing percarbonate and methods of feeding same
GB201816558D0 (en) 2018-10-10 2018-11-28 Slainte Beoga Teoranta Antibiotic-free antimicrobial feed additives and antimicrobial compositions
IT202100020846A1 (it) * 2021-08-03 2023-02-03 Moss Pharma S R L Nuovo uso veterinario di un olio vegetale

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567036A (en) * 1983-12-30 1986-01-28 Simon Gilbert I Chemotherapeutic method for treating periodontal disease, and composition therefore
SU1600666A1 (ru) * 1987-12-15 1990-10-23 Научно-Исследовательский Институт Земледелия И Животноводства Западных Районов Усср Способ консервировани молока и продуктов его переработки
US4935248A (en) * 1988-07-28 1990-06-19 Albert L. Jacobs Antimicrobial veterinary compositions and methods
US5066497A (en) * 1988-07-28 1991-11-19 Albert L. Jacobs, Jr. Antimicrobial veterinary compositions and methods
GB9002422D0 (en) 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
WO1994009635A1 (en) * 1992-10-26 1994-05-11 Edward Shanbrom Starch-iodine-peroxide preservation of foods
US5639481A (en) * 1994-10-17 1997-06-17 Symbollon Corporation Method for the therapeutic treatment of a mammalian eye using an admixed composition containing free molecular iodine
US5849291A (en) * 1994-10-17 1998-12-15 Symbollon Corporation Opthalmic non-irritating iodine medicament
US5950269A (en) 1996-09-27 1999-09-14 Openshaw; Deryl E. Boot and shoe sole cleaner
US5916581A (en) * 1997-10-21 1999-06-29 West Agro, Inc. Iodine antimicrobial compositions containing nonionic surfactants and halogen anions
US6939569B1 (en) * 1998-06-19 2005-09-06 Oxibio, Inc. Medical device having anti-infective and contraceptive properties
JP2002003316A (ja) * 2000-06-21 2002-01-09 Mitsubishi Gas Chem Co Inc 殺菌剤組成物
JP4743570B2 (ja) 2001-04-10 2011-08-10 ルネサスエレクトロニクス株式会社 電源回路を内蔵した半導体集積回路および液晶表示制御装置並びに携帯用電子機器
JP4228175B2 (ja) * 2002-01-11 2009-02-25 三菱瓦斯化学株式会社 殺菌剤組成液及び殺菌方法
US6794181B2 (en) 2002-10-09 2004-09-21 Immucell Corporation Method of purifying lantibiotics
US20040091553A1 (en) * 2002-11-12 2004-05-13 West Agro, Inc Composition and method for mammary disinfection during winter conditions
US20070292360A1 (en) * 2005-04-15 2007-12-20 Phyllis Siegel Process and composition for oral hygiene
US20070286907A1 (en) * 2005-12-29 2007-12-13 Gregg Siegel Germicide composition
EP2081588A1 (en) 2006-07-03 2009-07-29 Jean-Paul Perraudin Antimicrobial composition and uses thereof
IE20080365A1 (en) 2008-05-09 2010-03-16 Univ College Cork Nat Univ Ie Nisin derivatives and the use thereof
FR2941374B1 (fr) 2009-01-28 2011-03-11 Alaxia Utilisation d'une association synergique d'ions hypothiocyanites et/ou hypohalites et de lactoferrine pour la preparation pour le traitement de la mucoviscidose
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
RU2590825C2 (ru) * 2011-03-25 2016-07-10 Делаваль Холдинг Аб Местное дезинфицирующее средство, содержащее йод, обладающее низким содержанием поверхностно-активного вещества
EP2510944A1 (en) 2011-04-15 2012-10-17 National University of Ireland, Galway Treatment of bacterial infections

Also Published As

Publication number Publication date
AU2021225229A1 (en) 2021-09-30
EP3620158A1 (en) 2020-03-11
AU2014261429B2 (en) 2019-07-18
PL2991642T3 (pl) 2020-06-15
WO2014177590A1 (en) 2014-11-06
NZ713792A (en) 2021-02-26
US20160074436A1 (en) 2016-03-17
EP2991642A1 (en) 2016-03-09
AU2014261429A1 (en) 2015-11-12
EP2991642B1 (en) 2019-07-03
JP2020079290A (ja) 2020-05-28
JP2016517875A (ja) 2016-06-20
EP2799068A1 (en) 2014-11-05
CA2910243A1 (en) 2014-11-06
AU2019250188A1 (en) 2019-11-07
MX366894B (es) 2019-07-29
CN105263489A (zh) 2016-01-20
JP6783139B2 (ja) 2020-11-11
US20200254014A1 (en) 2020-08-13
BR112015027636A2 (pt) 2017-08-29
CN105263489B (zh) 2020-04-03

Similar Documents

Publication Publication Date Title
MX2022006525A (es) Activo de polipeptidos de lisina contra bacterias gram-negativas.
NZ713621A (en) Compounds and methods of treating infections
WO2016179440A3 (en) Antimicrobial therapy
MX366894B (es) Composiciones antimicrobianas y métodos para su producción.
MX2017012545A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
TW201613575A (en) Treatment of polybacterial infections
WO2016142445A3 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
WO2017075188A3 (en) Methods of using anti-alpha toxin antibody
EP3787668C0 (en) PROBIOTIC BACTERIAL STRAINS THAT PRODUCE ANTIMICROBIAL PROTEINS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF A CLOSTRIDIUM DIFFICILE INFECTION
MX2019001633A (es) Proteina derivada de la seda para el tratamiento de la inflamacion.
ZA202002093B (en) Antibacterial compounds
WO2017218922A3 (en) Compositions and methods for the treatment of bacterial infections
MX2017012535A (es) Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
WO2016105510A3 (en) Methods and compositions for growth, storage, and use of bacterial preparations for wound and surface treatments
NZ728796A (en) Aqueous formulation comprising paracetamol and ibuprofen
MX2017014080A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
WO2014152437A3 (en) Methods of use for an antimicrobial peptide
MX344183B (es) Proteina antimicrobiana.
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.
MX2013013182A (es) Tratamiento de la mastitis.
BR112022015321A2 (pt) Composição e método para tratamento de mastite e método de tratamento de mastite em uma vaca ou cabra leiteira
MA39955A (fr) Compositions désinfectantes et antimicrobiennes, en particulier pour le domaine vétérinaire
MX2018011095A (es) Compuestos de carbapenem.
MX2017012539A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.

Legal Events

Date Code Title Description
FG Grant or registration